BEIJING HOTGEN BIOTECH financial statements, including revenue, expenses, profit, and loss
The total revenue of 688068 for the last quarter is 136.25 M CNY, and it's 4.37% higher compared to the previous quarter. The net income of Q3 24 is 2.83 M CNY.